SNP-based analysis of neuroactive ligand-receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: Data from the CATIE study

被引:39
作者
Adkins, Daniel E. [1 ]
Khachane, Amit N. [1 ]
McClay, Joseph L. [1 ]
Aberg, Karolina [1 ]
Bukszar, Jozsef [1 ]
Sullivan, Patrick F. [2 ,3 ,4 ,5 ]
van den Oord, Edwin J. C. G. [1 ]
机构
[1] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Sch Pharm, Richmond, VA 23298 USA
[2] Univ N Carolina, Dept Genet, Chapel Hill, NC USA
[3] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA
[4] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA
[5] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
关键词
SCHIZOPHRENIA; ASSOCIATION; DRUGS;
D O I
10.1016/j.schres.2011.11.002
中图分类号
R749 [精神病学];
学科分类号
100204 [神经病学];
摘要
引用
收藏
页码:200 / 201
页数:2
相关论文
共 10 条
[1]
Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E2 concentration in rat brain [J].
Cheon, Yewon ;
Park, Jee-Young ;
Modi, Hiren R. ;
Kim, Hyung-Wook ;
Lee, Ho-Joo ;
Chang, Lisa ;
Rao, Jagadeesh S. ;
Rapoport, Stanley I. .
JOURNAL OF NEUROCHEMISTRY, 2011, 119 (02) :364-376
[2]
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia [J].
Lieberman, JA ;
Stroup, TS ;
McEvoy, JP ;
Swartz, MS ;
Rosenheck, RA ;
Perkins, DO ;
Keefe, RSE ;
Davis, SM ;
Davis, CE ;
Lebowitz, BD ;
Severe, J ;
Hsiao, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) :1209-1223
[3]
The Edinburgh human metabolic network reconstruction and its functional analysis [J].
Ma, Hongwu ;
Sorokin, Anatoly ;
Mazein, Alexander ;
Selkov, Alex ;
Selkov, Evgeni ;
Demin, Oleg ;
Goryanin, Igor .
MOLECULAR SYSTEMS BIOLOGY, 2007, 3 (1)
[4]
The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia [J].
Martinez-Gras, Isabel ;
Perez-Nievas, Beatriz G. ;
Garcia-Bueno, Borja ;
Madrigal, Jose L. M. ;
Andres-Esteban, Eva ;
Rodriguez-Jimenez, Roberto ;
Hoenicka, Janet ;
Palomo, Tomas ;
Rubio, Gabriel ;
Leza, Juan C. .
SCHIZOPHRENIA RESEARCH, 2011, 128 (1-3) :15-22
[5]
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics [J].
McClay, J. L. ;
Adkins, D. E. ;
Aberg, K. ;
Stroup, S. ;
Perkins, D. O. ;
Vladimirov, V. I. ;
Lieberman, J. A. ;
Sullivan, P. F. ;
van den Oord, E. J. C. G. .
MOLECULAR PSYCHIATRY, 2011, 16 (01) :76-85
[6]
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs [J].
Miyamoto, S ;
Duncan, GE ;
Marx, CE ;
Lieberman, JA .
MOLECULAR PSYCHIATRY, 2005, 10 (01) :79-104
[7]
The positive false discovery rate:: A Bayesian interpretation and the q-value [J].
Storey, JD .
ANNALS OF STATISTICS, 2003, 31 (06) :2013-2035
[8]
Genomewide association for schizophrenia in the CATIE study: results of stage 1 [J].
Sullivan, P. F. ;
Lin, D. ;
Tzeng, J-Y ;
van den Oord, E. ;
Perkins, D. ;
Stroup, T. S. ;
Wagner, M. ;
Lee, S. ;
Wright, F. A. ;
Zou, F. ;
Liu, W. ;
Downing, A. M. ;
Lieberman, J. ;
Close, S. L. .
MOLECULAR PSYCHIATRY, 2008, 13 (06) :570-584
[9]
A systematic method for estimating individual responses to treatment with antipsychotics in CATIE [J].
van den Oord, Edwin J. C. G. ;
Adkins, Daniel E. ;
McClay, Joseph ;
Lieberman, Jeffrey ;
Sullivan, Patrick F. .
SCHIZOPHRENIA RESEARCH, 2009, 107 (01) :13-21
[10]
Analysing biological pathways in genome-wide association studies [J].
Wang, Kai ;
Li, Mingyao ;
Hakonarson, Hakon .
NATURE REVIEWS GENETICS, 2010, 11 (12) :843-854